Company newsroom

Intensity Therapeutics Inc.

NASDAQ:INTS

2 releases

Intensity Therapeutics Inc.7h ago

Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026

Company to hold a conference call at 8AM ET on November 5, 2026 to review results and provide a corporate update SHELTON, Conn., Oct. 30, 2026 —…

Intensity Therapeutics Inc.Oct 23, 2026

Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting

Pathological complete response (pCR) achieved in the breast (ypT0/Tis) and affected lymph nodes (ypN0) in 5 out of 7 patients (71%; 95% CI 29-96%) in…